logo

BENF

Beneficient·NASDAQ
--
--(--)
--
--(--)
8.77 / 10
Outperform

Fundamental analysis rates BENF as Outperform with an 8.8/10 health score. Revenue‑to‑Market‑Value and cash metrics are positive, as are Days Sales Outstanding and receivables turnover. Concerns arise from operating‑revenue YoY growth and asset‑to‑market‑value ratios, but overall fundamentals remain robust.

Fundamental(8.77)SentimentTechnical

Analysis Checks(6/10)

Revenue-MV
Value-0.11
Score2/3
Weight13.26%
1M Return1.93%
Days sales outstanding
Value223.49
Score2/3
Weight4.74%
1M Return0.68%
Profit-MV
Value0.66
Score3/3
Weight93.48%
1M Return14.92%
Accounts receivable turnover ratio
Value23.42
Score3/3
Weight4.93%
1M Return0.71%
PB-ROE
Value-0.88
Score1/3
Weight-12.98%
1M Return-2.01%
Net cash flow from operating activities (YoY growth rate %)
Value35.24
Score3/3
Weight24.18%
1M Return3.28%
Cash-UP
Value-0.15
Score2/3
Weight-11.82%
1M Return-2.12%
Operating revenue (YoY growth rate %)
Value177.16
Score1/3
Weight-4.32%
1M Return-0.60%
Asset-MV
Value-0.55
Score1/3
Weight-5.37%
1M Return-1.02%
Cash-MV
Value0.02
Score1/3
Weight-6.10%
1M Return-1.18%
Is BENF fundamentally strong?
  • BENF scores 8.77/10 on fundamentals and holds a Discounted valuation at present. Backed by its -555.72% ROE, 539.10% net margin, -0.94 P/E ratio, -1.22 P/B ratio, and -131.82% earnings growth, these metrics solidify its Outperform investment rating.